LINEAGE THERAPEUTICS INC. – Trademark Portfolio

Entity Type: 03

LINEAGE THERAPEUTICS INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ADRENACLICK. The owner is based in HORSHAM, PA.

2 WALNUT GROVE DRIVE

SUITE 190

HORSHAM, PA 190447707

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LINEAGE THERAPEUTICS INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does LINEAGE THERAPEUTICS INC. have?

LINEAGE THERAPEUTICS INC. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 cancelled.

What trademark classes does LINEAGE THERAPEUTICS INC. file in?

LINEAGE THERAPEUTICS INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are LINEAGE THERAPEUTICS INC.'s most well-known trademarks?

LINEAGE THERAPEUTICS INC.'s registered trademark portfolio includes well-known marks such as ADRENACLICK. These are among 1 currently registered trademark in the portfolio.

What is LINEAGE THERAPEUTICS INC.'s trademark registration success rate?

LINEAGE THERAPEUTICS INC. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.